Those changes are considered instrumental steps in promoting the reversal of the epithelial–mesenchymal transition [42], while modulation of vinculin, ROCK1, and uPA will finally antagonize the invasive/migratory proneness of breast cancer cells. Here, VCL is linked to breast cancer.